arrow
M

Marjolijn Duijvestein

radboud university nijmegen
H指数:32
被引数:4,646

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Incidence and predictors of surgical recurrence after primary ileocolic resection in Crohn ileitis: a systematic review and meta-analysis

克罗恩回结肠炎初次回结肠切除术后手术复发的发病率和预测因素:一项系统评价和荟萃分析

2026-04-190
OA
Prospective real-world experience with risankizumab in difficult-to-treat Crohn’s disease: results from the Dutch Initiative on Crohn and Colitis Registry

利那利珠单抗在难治性克罗恩病中的前瞻性真实世界经验:荷兰克罗恩病和结肠炎登记研究的结果

2026-04-040
OA
Pharmacokinetics and transcriptomic analysis reveal the molecular signature of mucosal healing in patients with Acute Severe Ulcerative Colitis treated with infliximab (PROTOS)

药代动力学和转录组学分析揭示接受英夫利昔单抗治疗的急性重度溃疡性结肠炎患者黏膜愈合的分子特征 (PROTOS)

2026-01-010
PRE
The societal burden of perianal fistulizing Crohn's disease: high costs driven by absenteeism in a prospective nationwide Dutch cohort study

肛周瘘性克罗恩病的社会负担:一项前瞻性荷兰全国队列研究发现缺勤是高昂费用的驱动因素

2026-01-010
PRE
The effect of intensive physical exercise on fatigue and quality of life in patients with quiescent inflammatory bowel disease: a multicentre randomised controlled trial (ENERGIZE-IBD trial)

高强度体育锻炼对缓解期炎症性肠病患者疲劳和生活质量的影响:一项多中心随机对照试验(ENERGIZE-IBD试验)

2026-01-010
PRE
Pre-Treatment Immune Signatures and Cytokine Patterns Associated with Vedolizumab Response in Inflammatory Bowel Disease: A Pilot Study

vedolizumab应答相关的炎症性肠病预治疗免疫特征和细胞因子模式:一项初步研究

Cells
IF5.2
2026-01-010
OA
Divergence between clinical and biochemical disease activity status in patients with Ulcerative Colitis - Result from the Dutch Initiative on Crohn and Colitis (ICC) Registry

溃疡性结肠炎患者中临床与生化疾病活动状态的差异——荷兰克罗恩病和结肠炎倡议(ICC)登记研究的结果

2026-01-010
PRE
Serum concentrations of infliximab are comparable with and without immunosuppression during subcutaneous infliximab induction treatment for Crohn's disease

在克罗恩病皮下注射英夫利昔单抗诱导治疗期间,有或无免疫抑制时血清英夫利昔单抗浓度相当

2026-01-010
PRE
Effectiveness of JAK inhibitors in JAK naïve Ulcerative Colitis patients: Comparative analysis of tofacitinib, filgotinib and upadacitinib in the Dutch ICC Registry

JAK抑制剂在JAK初治溃疡性结肠炎患者中的有效性:荷兰ICC登记研究中托法替尼、菲戈替尼和乌帕替尼的比较分析

2026-01-010
PRE
Filgotinib Is an Effective and Safe Treatment Option for Difficult-To-Treat Ulcerative Colitis: Real-World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry

Filgotinib 是一种有效且安全的难治性溃疡性结肠炎治疗选择:荷兰克罗恩病和结肠炎倡议 (ICC) 登记研究的真实世界证据

2025-12-010
OAAI
Promoting Well-Being Among Gastroenterologists - A Call for Systemic Action

促进胃肠病医生福祉——系统性行动的呼吁

2025-12-010
OAAI
Reliability and Responsiveness of Endoscopic Indices for Assessing Crohn’s Disease Postoperative Recurrence in the PREVENT trial

PREVENT试验中用于评估克罗恩病术后复发的内镜指数的可靠性与反应性

2025-09-020
OAAI
Preoperative body composition parameters are associated with postoperative outcomes in patients with Crohn’s disease

术前体成分参数与克罗恩病患者的术后结局相关。

2025-07-280
OAAI